1. Home
  2. JWEL vs CDIO Comparison

JWEL vs CDIO Comparison

Compare JWEL & CDIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Jowell Global Ltd.

JWEL

Jowell Global Ltd.

N/A

Current Price

$1.76

Market Cap

5.7M

ML Signal

N/A

Logo Cardio Diagnostics Holdings Inc.

CDIO

Cardio Diagnostics Holdings Inc.

N/A

Current Price

$1.65

Market Cap

6.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
JWEL
CDIO
Founded
2012
2017
Country
China
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Commercial Physical & Biological Resarch
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.7M
6.1M
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
JWEL
CDIO
Price
$1.76
$1.65
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
5.2K
★ 14.9K
Earning Date
04-30-2026
12-01-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $14,825.00
Revenue This Year
N/A
$168,534.06
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$1.47
$0.97
52 Week High
$5.17
$7.91

Technical Indicators

Market Signals
Indicator
JWEL
CDIO
Relative Strength Index (RSI) 39.71 41.69
Support Level $1.47 $1.53
Resistance Level $2.52 $2.20
Average True Range (ATR) 0.20 0.13
MACD 0.01 -0.00
Stochastic Oscillator 7.80 12.87

Price Performance

Historical Comparison
JWEL
CDIO

About JWEL Jowell Global Ltd.

Jowell Global Ltd is a cosmetics, health, nutritional supplements, and household products e-commerce platform in China. The company offers its branded products to customers and also sells and distributes products from other companies on its platform. In addition, it allows third parties to open their stores on its platform for a service fee based on their sales revenues generated from their online stores and provides them with information about market needs, enabling them to manage their sales effort, as well as an effective platform to promote their brands. The company currently operates under four sales channels: Online Direct Sales, Authorized Retail Store Distribution, Third-party Merchants, and Live streaming marketing.

About CDIO Cardio Diagnostics Holdings Inc.

Cardio Diagnostics Holdings Inc is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular diseases and associated comorbidities by leveraging its Artificial Intelligence (AI)-driven Multi-Omics Engine. The company has developed two clinical products: Epi+Gen CHD and PrecisionCHD, epigenetics-based clinical blood tests capable of assessing risk for a coronary heart disease (CHD) event, including heart attacks. Additionally, its portfolio includes HeartRisk, a cardiovascular disease risk intelligence platform, and CardioInnovate360, a research-use-only solution launched to support the discovery, development, and validation of novel biopharmaceuticals for the assessment and management of cardiovascular diseases.

Share on Social Networks: